Boehringer Ingelheim receives Health Canada approval for SENVELGO™, the once-daily liquid oral solution for newly diagnosed diabetes in cats
Weekly Voice,
Boehringer Ingelheim (Canada) Ltd. (CNW Group/Boehringer Ingelheim Canada Ltd.) Share on FacebookShare on TwitterShare on…